Form 4/A for SMTI Sanara MedTech Inc.
Accepted 2026-05-05 16:05:20 ET · period of report 2026-03-22 · accession 0001493152-26-021296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-05-05 16:05 | 2026-03-22 | SMTI | Mackey Ashley M | Ctrl | A - Grant | $0.00 | +2,804 | 4,967 | +130% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-22 | A | A | 2,804 | $0.00 | 4,967 | D | — | — | (F1) Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. (F1) Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. (F1) Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date. (F2) The original Form 4, filed on March 23, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of the Issuer reported as being beneficially owned by the reporting person. The original Form 4 mistakenly indicated that the reporting person held 5,067 shares of common stock, when in fact, as reported in this amendment, the reporting person held 4,967 shares of common stock following the reported transaction. |